We are live on ! Find out more
IRAG

Investment Research & Advisory Group Portfolio holdings

AUM $324M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
+8.68%
1 Year Est. Return
+22.57%
3 Year Est. Return
+88.65%
5 Year Est. Return
+107.32%
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$15.6M
Cap. Flow
+$15.3M
Cap. Flow %
10.11%
Top 10 Hldgs %
53.32%
Holding
183
New
42
Increased
46
Reduced
18
Closed
7

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$12.3M
2
BDX icon
Becton Dickinson
BDX
+$1.37M
3
IVW icon
iShares S&P 500 Growth ETF
IVW
+$704K
4
IVE icon
iShares S&P 500 Value ETF
IVE
+$616K
5
BBEU icon
JPMorgan BetaBuilders Europe ETF
BBEU
+$334K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.3M
2
MA icon
Mastercard
MA
+$153K
3
TSM icon
TSMC
TSM
+$111K
4
PG icon
Procter & Gamble
PG
+$98.8K
5
MCK icon
McKesson
MCK
+$97K

Sector Composition

Rank Sector Weight
1 Financials 19.88%
2 Technology 16.61%
3 Consumer Discretionary 10.76%
4 Healthcare 9.39%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLD icon
101
Prologis
PLD
$133B
$58K 0.04%
488
– –
MO icon
102
Altria Group
MO
$114B
$57K 0.04%
1,197
– –
EIX icon
103
Edison International
EIX
$26.4B
$56K 0.04%
967
– –
DUK icon
104
Duke Energy
DUK
$97.3B
$54K 0.04%
550
– –
MHK icon
105
Mohawk Industries
MHK
$9.22B
$52K 0.03%
269
– –
PSX icon
106
Phillips 66
PSX
$81.4B
$52K 0.03%
611
– –
WDAY icon
107
Workday
WDAY
$44.4B
$50K 0.03%
209
– –
ZBH icon
108
Zimmer Biomet
ZBH
$18.4B
$48K 0.03%
309
– –
LH icon
109
Labcorp
LH
$25.9B
$47K 0.03%
198
– –
TD icon
110
Toronto Dominion Bank
TD
$200B
$47K 0.03%
667
– –
NUV icon
111
Nuveen Municipal Value Fund
NUV
$1.91B
$46K 0.03%
3,955
– –
SHY icon
112
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$46K 0.03%
+533
New +$46K
C icon
113
Citigroup
C
$226B
$45K 0.03%
631
+81
+15% +$5.99K
COP icon
114
ConocoPhillips
COP
$141B
$36K 0.02%
585
+148
+34% +$8.25K
VMBS icon
115
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
$36K 0.02%
+674
New +$36K
CHKP icon
116
Check Point Software Technologies
CHKP
$13.1B
$35K 0.02%
300
– –
HRL icon
117
Hormel Foods
HRL
$13.8B
$35K 0.02%
728
– –
SCHX icon
118
Schwab US Large- Cap ETF
SCHX
$74.6B
$29K 0.02%
1,662
– –
CRUS icon
119
Cirrus Logic
CRUS
$6.26B
$26K 0.02%
300
– –
GSK icon
120
GSK
GSK
$106B
$24K 0.02%
480
– –
PFGC icon
121
Performance Food Group
PFGC
$18B
$24K 0.02%
500
– –
MMP
122
DELISTED
Magellan Midstream Partners, L.P.
MMP
$24K 0.02%
500
– –
VTR icon
123
Ventas
VTR
$47.9B
$22K 0.01%
383
– –
GILD icon
124
Gilead Sciences
GILD
$165B
$21K 0.01%
300
– –
SCHG icon
125
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$21K 0.01%
1,168
– –
3 4
5
6 7

Similar funds

AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return

Investment Research & Advisory Group's Q2 2021 Portfolio in Review

As of Q2 2021, Investment Research & Advisory Group held 183 positions worth $152M, up 11% from $136M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Investment Research & Advisory Group deployed $15.3M of net new capital in Q2 2021, opening 42 new positions and adding to 46 existing holdings. Its largest new stake was iShares S&P 500 Growth ETF: 10,164 shares worth $739K.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Novartis, an estimated $1.3M trimmed.

  • Investment Research & Advisory Group's largest Q2 2021 buy was iShares S&P 500 Growth ETF: 10,164 shares worth $739K.
  • Investment Research & Advisory Group added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $12.3M increase.
  • Investment Research & Advisory Group's biggest Q2 2021 reduction was Novartis, cutting an estimated $1.3M.
  • Investment Research & Advisory Group fully exited McKesson in Q2 2021, selling an estimated $97K.
  • Investment Research & Advisory Group's ten largest holdings make up 53% of its $152M portfolio in Q2 2021.
  • Investment Research & Advisory Group opened 42 new positions and closed 7 in Q2 2021.
  • Investment Research & Advisory Group's portfolio value rose 11% quarter-over-quarter to $152M.

Based on Investment Research & Advisory Group's 13F filing for Q2 2021, filed 29 Jul 2021.